Value of Non-Drug Treatment and Drug Treatment in Hypertension L. J. Beilin State of the Art Lecture 20 October 2012 Pages: 1 - 9
Adrenergic Receptor Effects and Antihypertensive Actions of β-Adrenoceptor-Blocking Agents with Ancillary Properties Shoichi ImaiHajime NakaharaKeisuke Takeda State of the Art Lecture 20 October 2012 Pages: 10 - 19
Progress in Antihypertensive Therapy with a Multiple-Action Drug B. N. C. PrichardB. Tomlinson State of the Art Lecture 20 October 2012 Pages: 20 - 25
Combined Action Drugs in the Treatment of Hypertension Lennart Hansson State of the Art Lecture 20 October 2012 Pages: 26 - 30
Analysis of the Mechanism Underlying the Vasodilator Action of Carvedilol in Pithed Spontaneously Hypertensive Rats Hiroo HashimotoMakoto TanakaAkira Akashi Mode of Action and Haemodynamic 20 October 2012 Pages: 31 - 36
Vasodilating Mechanism and Response to Physiological Pressor Stimuli of Acute Doses of Carvedilol Compared with Labetalol, Propranolol and Hydralazine Brian TomlinsonFrancois BompartBrian N. C. Prichard Mode of Action and Haemodynamic 20 October 2012 Pages: 37 - 47
Haemodynamic Effects of New α-Blockers with Vasodilatory Properties in Essential Hypertension Hisaichiro TsukiyamaK. OtsukaM. Horii Mode of Action and Haemodynamic 20 October 2012 Pages: 48 - 54
Mode of Vasodilating Activity of Carvedilol in Isolated Perfused Hind Limbs of Rabbits G. SponerW. BartschL. Kling Short Communication 20 October 2012 Pages: 55 - 61
Pharmacological Profile of Vasodilating Action of Carvedilol in Isolated Canine Coronary Artery Yuichi HattoriHaruaki NakayaMorio Kanno Short Communication 20 October 2012 Pages: 62 - 63
Effects of Carvedilol on Plasma Hormonal and Biochemical Factors and Renal Function in Japanese Patients with Essential Hypertension Jitsuo HigakiToshio OgiharaYuichi Kumahara Short Communication 20 October 2012 Pages: 64 - 68
Influence of Carvedilol on the Responsiveness of Human Hand Veins to Noradrenaline and Dinoprost Gustav G. BelzC. BeermannG. Neugebauer Short Communication 20 October 2012 Pages: 69 - 74
Dose-Effect Relationship of Carvedilol in Essential Hypertension Toshio OgiharaYuichiro GotoThe Carvedilol Hypertension Study Group in Japan Studies in Hypertension 20 October 2012 Pages: 75 - 81
Effects of Carvedilol on Blood Pressure in Patients with Mild to Moderate Hypertension Joseph J. McPhillipsGregory T. SchwemerDaniel Patterson Studies in Hypertension 20 October 2012 Pages: 82 - 91
Response Rate with Respect to the Blood Pressure-Lowering Effect of the Vasodilating and β-Blocking Agent Carvedilol R. Rittinghausen Studies in Hypertension 20 October 2012 Pages: 92 - 101
Comparison of Antihypertensive Efficacy of Carvedilol, a New Vasodilating β-Blocker, versus Atenolol Raffaele De CesarisG. RanieriD. Bedoschi Short Communication 20 October 2012 Pages: 102 - 105
Two-Year Follow-Up of 24-Hour Indirect Blood Pressure Monitoring: An Open Study Wolfgang Meyer-SabellekKarl-Ludwig SchulteReinhard Gotzen Short Communication 20 October 2012 Pages: 106 - 112
Pharmacokinetic and Pharmacodynamic Interactions of Combined Acute Administration of Carvedilol and Hydrochlorothiazide in Hypertensive Volunteers J. E. RudorfB. Ehmer Short Communication 20 October 2012 Pages: 113 - 117
Efficacy and Tolerance of Carvedilol in Combination with a Thiazide Diuretic in the Treatment of Essential Hypertension Minoru YasujimaYuichiro GotoThe Carvedilol Hypertension Study Group in Japan Short Communication 20 October 2012 Pages: 118 - 123
Combination Therapy with Carvedilol and Nicardipine in Essential Hypertension Toshikazu TakabatakeHiromichi OhtaNobu Hattori Short Communications 20 October 2012 Pages: 124 - 128
Therapeutic Benefits and Safety of Carvedilol in the Treatment of Renal Hypertension Masakazu KohnoTadanao TakedaThe Carvedilol Renal Hypertension Study Group in Japan Studies in Special Patient Group 20 October 2012 Pages: 129 - 135
Influence of Carvedilol on Blood Glucose and Glycohaemoglobin A1 in Non-Insulin-Dependent Diabetics Bernhard EhmerReinhard van der DoesJoachim Rudorf Studies in Special Patient Group 20 October 2012 Pages: 136 - 140
Effects of Carvedilol on Left Ventricular Function in Essential Hypertension and Ischaemic Heart Disease A. LahiriE. A. RodriguesE. B. Raftery Short Communication 20 October 2012 Pages: 141 - 143
Pharmacokinetics of Carvedilol in Hypertensive Patients with Renal Failure H. HakusuiM. Fujimaki Short Communication 20 October 2012 Pages: 144 - 147
Pharmacokinetics and Bioavailability of Carvedilol in Patients with Liver Cirrhosis G. NeugebauerM. GaborK. Reiff Short Communication 20 October 2012 Pages: 148 - 154
Renal Vasodilatory Action of Carvedilol in the Dog Toshiaki TamakiKouichi HasuiYouichi Abe Short Communication 20 October 2012 Pages: 155 - 159
Effects of Carvedilol on Renal Function and Blood Pressure in Three-Fifths Nephrectomised Spontaneously Hypertensive Rats Loaded with High Salt H. NakamotoH. SuzukiH. Sakaguchi Short Communication 20 October 2012 Pages: 160 - 164
Effects of Long Term Administration of Carvedilol on Renal Haemodynamics and Functions in DOCA Salt-Induced Accelerated Hypertension of Spontaneously Hypertensive Rats Masakazu KohnoKoh-ichi MurakawaTadanao Takeda Short Communication 20 October 2012 Pages: 165 - 168
Double-Blind, Controlled Clinical Trial to Evaluate the Antihypertensive Effect of Carvedilol in Elderly Patients with Mild to Moderate Hypertension Ch. StaigerW. StegerW. Holtbrügge Short Communication 20 October 2012 Pages: 169 - 171
